Hugel, Inc. (KOSDAQ:145020)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals			319.70B	281.68B	231.86B	211.04B	204.57B
Pharmaceuticals Growth			13.50%	21.49%	9.87%	3.16%	12.16%
Total			319.70B	281.68B	231.86B	211.04B	204.57B
Total Growth			13.50%	21.49%	9.87%	3.16%	12.16%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Korea			142.73B	131.27B	113.49B	121.50B	122.97B
Korea Growth			8.73%	15.67%	-6.59%	-1.20%	21.30%
North & South America			27.54B	22.93B	13.10B	5.21B	8.62B
North & South America Growth			20.11%	75.04%	151.37%	-39.52%	6.48%
Asia			91.50B	83.00B	81.13B	67.01B	53.14B
Asia Growth			10.24%	2.32%	21.06%	26.10%	-7.39%
Europe and Middle East			45.24B	39.87B	21.22B	14.75B	17.11B
Europe and Middle East Growth			13.49%	87.89%	43.86%	-13.79%	12.04%
Other			12.68B	4.61B	2.93B	2.57B	2.73B
Other Growth			175.22%	57.31%	14.10%	-5.95%	926.59%
Discontinued Business (*)			-	10.34B	-	-	-
Total			319.70B	292.02B	231.86B	211.04B	204.57B
Total Growth			9.48%	25.95%	9.87%	3.16%	12.16%

Source: S&P Global Market Intelligence.